Senate honors glioblastoma patients, calls for research acceleration
S.Res. 285 — A resolution designating July 16, 2025, as "Glioblastoma Awareness Day". · Filed by Lindsey Graham (R-SC) · 9 cosponsors · Introduced Jun 17, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This resolution designates July 16, 2025, as 'Glioblastoma Awareness Day' to raise public awareness of glioblastoma, a deadly and aggressive brain cancer that kills over 10,000 Americans annually with a 6.9% five-year survival rate. The resolution honors patients and caregivers, calls for increased research funding and collaborative efforts to develop better treatments, and recognizes the Glioblastoma Therapeutics Network as a key infrastructure for advancing therapies.
Why we flagged it
This is a straightforward commemorative resolution designating a single day to raise awareness of a specific disease. It contains no legislative mechanism, appropriations, or regulatory change—only symbolic designation and expressions of support for research.
What the text implies
- The resolution's emphasis on the Glioblastoma Therapeutics Network (GTN) and call for 'continued investments' may signal congressional intent to prioritize funding for this specific research infrastructure in future appropriations bills, though no direct funding is mandated here.
- The detailed recitation of glioblastoma's severity, low survival rates, and limited FDA-approved treatments (only 5 drugs and 1 device since the 1920s) creates a legislative record that could support future bills seeking accelerated drug approval pathways or research grants specifically for brain tumors.
Who stands to gain
pharmaceutical companies developing glioblastoma treatments; medical device manufacturers; research institutions participating in the Glioblastoma Therapeutics Network